Australia's largest stock trading and investment forum Australia's #1 stock forum

MLA

Click for more information

0.00%

8.5¢ medical australia limited

Ann: Appendix 4C - quarterly, page-3

First 3 Last

Share
Profile

Follow
sydney6791

3,646 Posts.

8

25/10/17

17:59

Post #: 28192272
Share

Originally posted by imspartacus ↑

Immediate thoughts here... staff payments up (as per that comment in the SIA booklet) from circa 825k (Mar-17) to 951k this quarter.

"Employee benefit expenses is MLA's largest overhead, accounting for approximately 60-64% of overheads across the period reviewed. Employee benefits expenses have increased largely in line with sales growth, with employee expenses representing 24.1% , 24.2% and 24.5% of sales in FY 15A, FY16A and FY17A, respectively. Employee benefits expenses are budgeted to increase by $522k (16.2%) to $3.7m in FY18B, which represents 28.6% of budgeted sales. Management has advised that the increase relates to new staff hires associated with both the Tuta and Clements (including Ardo) divisions."

And surprisingly quarterly revenue's largely unchanged at $3.22m vs $3.18m Sep-16 quarter. In my view the headline cashflow reduction looks somewhat misleading, would be in line with the view that OEM revenue is on the decrease and significant gains in Ardo/Clements are continuing to offset as the sales team's experience and output gathers steam.

Solid 3.2m bid @ 8.4c still there.

all IMO, DYOR etc...

Expand

Still running at loss, $140k last quarter, and 1.3m cash left. donot know why the business is always not profitable.

MLA Price at posting: 8.4¢ Sentiment: Hold Disclosure: Not Held
Upvote

0 Great analysis

Reply

Top Stories

History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025

Dale Gillham's weekly wrap: Bold moves in NZ, caution in Australia

WC8

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

RSG

Resolute shares bounce back as second payment made to Mali government to secure workers' release

HotCopper Highlights: Your most watched stocks for Week 48, 2024

ACW

This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game

Ice-cold winner: Cryopreserver Vitrafy escapes November's IPO struggles to end debut week higher

Week 48 Wrap: ASX flirts with 8,500pts; APRA declines mortgage loan easing; Trump's Bessent tied to Dem donor

MIN

MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up

ADD

Parkes Au-Cu project to 'transform' Adavale Resources with key targets

There are more pages in this discussion • 8 more messages in this thread...

First 3 Last

Add MLA (ASX) to my watchlist